Bibliography

Export 53 results:

Filters: Keyword is Blood Donors [Clear All Filters]

2004

Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol. 2004;11(1):26-32.

Azmi B, Aminuddin BS, Sharaf I, Samsudin OC, Munirah S, Chua KH, et al. The significance of using pooled human serum in human articular cartilage tissue engineering. Med J Malaysia. 2004;59 Suppl B:13-4.

de Oliveira AM, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion//Transfusion. 2004;44(12):1695-9.

2003

Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871-9.

Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003;43(6):696-704.

Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348(22):2196-203.

2002

Kjemtrup AM, Lee B, Fritz CL, Evans C, Chervenak M, Conrad PA. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion//Transfusion. 2002;42(11):1482-7.

2001

Moog R. Adverse events in peripheral progenitor cell collection: a 7-year experience. J Hematother Stem Cell Res. 2001;10(5):675-80.

Korbling M, Giralt S, Khouri I, Mirza N, Donato M, Anderlini P, et al. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis. Journal of Clinical Apheresis. 2001;16(2):82-7.

Win N, Montgomery J, Sage D, Street M, Duncan J, Lucas G. Recurrent transfusion-related acute lung injury. Transfusion//Transfusion. 2001;41(11):1421-5.

2000

Linden JV, Wong SJ, Chu FK, Schmidt GB, Bianco C. Transfusion-associated transmission of babesiosis in New York State. Transfusion//Transfusion. 2000;40(3):285-9.

Turner ML, Ludlam CA. Variant Creutzfeldt-Jakob disease. Transfus Med Rev. 2000;14(3):216-22.

1999

Creange A, Duvoux C, Gray F, Dhumeaux D. [Prion diseases, the liver and the digestive system]. Gastroenterol Clin Biol. 1999;23(10):1013-8.

1998

Anderlini P, Przepiorka D, Körbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant. 1998;21 Suppl 3:S35-9.

Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplantation proceedings//Transplant Proc. 1998;30(4):1324-6.

Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc. 1998;30(4):1324-6.

Pillonel J, Saura C, Couroucé AM. [Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996]. Transfus Clin Biol. 1998;5(5):305-12.

1997

Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90(3):903-8.

Teshima A, Harada M. Mobilization of peripheral blood progenitor cells for allogeneic transplantation. Cytokines, Cellular & Molecular Therapy. 1997;3(2):101-14.

1996

Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334(26):1685-90.

Bensinger WI, Buckner CD, Rowley S, Storb R, Appelbaum FR. Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant. 1996;17 Suppl 2:S19-21.

1995

Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 1995;35(2):91-7.

1991

Keilholz U, Klein HG, x00F, Korbling M, Brado B, Carter CS, et al. Peripheral blood mononuclear cell collection from patients undergoing adoptive immunotherapy or peripheral blood-derived stem cell transplantation and from healthy donors. Journal of Clinical Apheresis. 1991;6(3):131-6.

1989

Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. The New England journal of medicine//N Engl J Med. 1989;321(22):1494-500.

1984

Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. The New England journal of medicine//N Engl J Med. 1984;310(2):69-75.

Pages